Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[siRNAs targeting La, hVAP-33, eIF2Bgamma, and HCV IRES inhibit the replication and expression of HCV in Huh7 cells].

Wang MX, Xu B, Duan J, Fu XQ, Jin M.

Zhonghua Gan Zang Bing Za Zhi. 2012 Oct;20(10):769-73. doi: 10.3760/cma.j.issn.1007-3418.2012.10.013. Chinese.

PMID:
23207339
2.

Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus.

Zhang J, Yamada O, Sakamoto T, Yoshida H, Iwai T, Matsushita Y, Shimamura H, Araki H, Shimotohno K.

Virology. 2004 Mar 1;320(1):135-43.

3.

Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes.

Xue Q, Ding H, Liu M, Zhao P, Gao J, Ren H, Liu Y, Qi ZT.

Arch Virol. 2007;152(5):955-62. Epub 2007 Feb 3.

PMID:
17273891
4.

Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.

Kruger M, Beger C, Li QX, Welch PJ, Tritz R, Leavitt M, Barber JR, Wong-Staal F.

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8566-71.

5.

La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication.

Shirasaki T, Honda M, Mizuno H, Shimakami T, Okada H, Sakai Y, Murakami S, Wakita T, Kaneko S.

J Infect Dis. 2010 Jul 1;202(1):75-85. doi: 10.1086/653081.

PMID:
20497049
6.

Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation.

Ali N, Pruijn GJ, Kenan DJ, Keene JD, Siddiqui A.

J Biol Chem. 2000 Sep 8;275(36):27531-40.

7.

Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.

Khaliq S, Jahan S, Pervaiz A, Ali Ashfaq U, Hassan S.

Virol J. 2011 May 13;8:221. doi: 10.1186/1743-422X-8-221.

9.
10.

Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an HCV-infected cell model.

Xing XK, Li SJ, He JL, Chen Z.

Biotechnol Lett. 2012 Feb;34(2):295-301. doi: 10.1007/s10529-011-0761-y. Epub 2011 Oct 5.

PMID:
21972147
11.
13.

Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.

Ali Ashfaq U, Ansar M, Sarwar MT, Javed T, Rehman S, Riazuddin S.

Virol J. 2011 Mar 10;8:112. doi: 10.1186/1743-422X-8-112.

16.

Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication.

Domitrovich AM, Diebel KW, Ali N, Sarker S, Siddiqui A.

Virology. 2005 Apr 25;335(1):72-86.

17.

Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication.

Mandal A, Ganta KK, Chaubey B.

Hepat Res Treat. 2016;2016:9671031. doi: 10.1155/2016/9671031. Epub 2016 Jun 29.

18.

Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs.

Chevalier C, Saulnier A, Benureau Y, Fléchet D, Delgrange D, Colbère-Garapin F, Wychowski C, Martin A.

Mol Ther. 2007 Aug;15(8):1452-62. Epub 2007 May 15.

19.
20.

A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.

Das S, Ott M, Yamane A, Tsai W, Gromeier M, Lahser F, Gupta S, Dasgupta A.

J Virol. 1998 Jul;72(7):5638-47. Erratum in: J Virol 1998 Nov;72(11):9419.

Supplemental Content

Support Center